Keyword Index
Fri, 10/09/2009 - 10:23 — admin
| Keyword | Abstracts |
| Affected relative pairs | 84, 161, 205 |
| Analysis of re-sequencing data | 2, 5, 13, 19, 42, 48, 206, 207 |
| Ascertainment | 34, 37, 91, 168, 231 |
| Association | 1, 6, 7, 8, 10, 18, 21, 22, 37, 43, 55, 60, 61, 62, 64, 66, 69, 70, 71, 80, 81, 84, 86, 94, 102, 108, 110, 111, 112, 122, 125, 126, 127, 130, 133, 134, 137, 139, 140, 142, 143, 145, 146, 148, 150, 151, 153, 156, 157, 173, 174, 175, 176, 178, 179, 180, 185, 188, 193, 195, 204, 207, 208, 209, 214, 221, 232, 240, 241, 243, 248, 249, 250, 253, 255, 259 |
| Autoimmune disorders | 44 |
| Bayesian analysis | 24, 25, 28, 33, 45, 47, 66, 74, 120, 188, 189, 222, 231, 242, 251, 259 |
| Bioinformatics | 15, 20, 50, 51, 52, 53, 54, 63, 66, 75, 92, 100, 112, 123, 138, 181, 183, 187, 188, 194, 212, 216, 225, 233, 254 |
| Cancer | 4, 13, 40, 42, 48, 60, 75, 82, 121, 140, 189, 196, 197, 199, 202, 203, 210, 227, 228, 229, 239, 247, 248 |
| Cardiovascular risk factors and hypertension | 9, 29, 47, 55, 65, 86, 93, 115, 163, 170, 224, 237, 246 |
| Case-Control Studies | 6, 8, 13, 18, 20, 24, 38, 40, 43, 44, 48, 50, 57, 58, 61, 64, 65, 67, 71, 82, 93, 102, 104, 109, 113, 116, 122, 128, 130, 132, 134, 136, 139, 143, 149, 150, 151, 152, 155, 179, 182, 193, 200, 208, 227, 229, 241 |
| Case-only design | 121 |
| Causation | 72, 94, 241 |
| Copy Number Variation | 18, 63, 149, 206, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 228 |
| Data mining | 15, 53, 54, 58, 76, 120, 132, 187, 200, 233 |
| Diabetes | 21, 124, 133, 141, 143, 165, 173, 185, 214, 225 |
| Familial aggregation and segregation analysis | 12, 91, 201, 202, 203, 231, 233, 237, 239 |
| Family-based Association Studies | 5, 11, 22, 26, 32, 33, 34, 35, 37, 38, 39, 40, 41, 59, 77, 80, 107, 131, 135, 147, 157, 163, 172, 192, 206, 221, 223, 243, 245, 258 |
| Fine mapping | 2, 4, 42, 45, 46, 98, 165, 170, 247 |
| Gene - environment interactions | 10, 23, 39, 70, 121 |
| Gene expression arrays | 30, 181, 199, 244 |
| Gene expression patterns | 3, 16, 26, 27, 29, 118 |
| Gene-environment interaction | 6, 25, 34, 35, 56, 60, 75, 77, 78, 79, 80, 81, 82, 83, 90, 110, 190, 235, 254 |
| Genetic Pathways | 3, 16, 17, 25, 28, 63, 72, 93, 118, 174, 177, 182, 184, 185, 189, 190, 191 |
| Genome scan | 3, 10, 14, 16, 17, 20, 21, 22, 23, 33, 46, 57, 74, 101, 110, 113, 115, 116, 119, 122, 123, 124, 126, 127, 130, 131, 132, 133, 139, 140, 141, 142, 145, 146, 148, 149, 151, 155, 156, 157, 159, 160, 166, 169, 171, 204, 217, 258 |
| Genomic variation | 14, 89, 92, 118, 144, 191, 198, 215, 220, 232 |
| Haplotype analysis | 4, 7, 31, 77, 92, 95, 96, 144, 234, 247, 251 |
| Heritability | 85, 87, 88, 90, 236 |
| Heterogeneity, Homogeneity | 49, 52, 72, 83, 229, 235 |
| Inbreeding, isolate populations | 9, 103, 104, 146, 154, 230 |
| Late onset Disease | 119, 145, 153, 168 |
| Liability | 12, 195 |
| Linkage analysis | 27, 46, 49, 161, 162, 163, 164, 165, 166, 169, 171, 230, 253 |
| Linkage and association | 2, 11, 39, 47, 68, 78, 89, 117, 128, 154, 160, 167, 170, 172, 223, 224, 254, 256 |
| Machine Learning Tools | 15, 51, 52, 54, 73, 76, 154, 187, 199 |
| Markov Chain Monte Carlo methods | 95, 168, 190 |
| Maximum likelihood methods | 1, 62, 64, 103, 106, 164, 236, 238, 239, 244 |
| Missing data, genotyping errors | 107, 109, 117, 129, 137, 147, 158, 161, 175, 201, 217, 252 |
| Multifactorial Diseases | 7, 19, 26, 57, 61, 67, 84, 91, 162, 183, 198, 215, 240, 245 |
| Multilocus analysis | 24, 44, 49, 51, 59, 62, 65, 68, 69, 70, 71, 74, 95, 96, 103, 109, 125, 136, 138, 148, 178, 184, 246, 253 |
| Multiple marker disequilibrium analysis | 19, 32, 89, 136, 225, 243 |
| Multivariate phenotypes | 56, 155, 201, 244 |
| Mutation analysis | 196, 203 |
| Pedigree likelihood | 35, 159, 197 |
| Pharmacogenetics | 193, 196, 226, 255 |
| Population stratification | 8, 14, 38, 41, 68, 73, 97, 98, 99, 101, 102, 104, 105, 108, 197 |
| Quantitative trait analysis | 5, 9, 27, 29, 30, 55, 69, 76, 83, 85, 115, 124, 131, 138, 141, 142, 147, 153, 160, 162, 164, 169, 171, 174, 207, 224, 236 |
| Sample size | 1, 11, 50, 78, 85, 94, 134, 255 |
| Sequential study design | 127 |
| Single nucleotide polymorphism | 12, 30, 43, 58, 86, 97, 98, 112, 119, 120, 135, 156, 173, 178, 179, 182, 183, 184, 191, 195, 200, 227, 232, 240, 245, 246, 248, 252, 257 |
| Transmission / disequilibrium test | 41, 59 |